FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2794187412> ?p ?o ?g. }

• W2794187412 abstract "T-cell-depleted, haploidentical transplantations (haplos) are commonly offered to patients who have high-risk, acute leukemia in the absence of a human leukocyte antigen (HLA) full-matched donor.To determine the effect of transplantation period, the authors divided 308 adults with de novo, acute leukemia who underwent T-cell-depleted haplo from 2005 to 2015 into 2 groups, according the year in which they underwent transplantation (2005-2011 [n = 191] and 2012-2015 [n = 117]).The median age was 41 years in patients who underwent transplantation before 2012 and 46 years in those who underwent transplantation after 2012 (P = .04). Most patients had acute myeloid leukemia (75% vs 69%; P = .26) and were in first complete remission (CR1) (55% vs 64%; P = .12) at the time of transplantation. The cumulative incidence of grade 2, 3, and 4 acute graft-versus-host disease (GvHD) and chronic GvHD were not different between the 2 groups (acute GvHD: 20% vs 22% cumulative incidence in patients who underwent haplo before and after 2012, respectively [P = .67]; chronic GvHD: 19% vs 11% cumulative incidence, respectively; P = .12]. The 2-year relapse incidence was 20%, the nonrelapse mortality (NRM) rate was 48%, and no difference was observed over time (21% vs 19% [P = .72] and 54% vs 38% [P = .11] for patients who underwent haplo before and after 2012, respectively). The main cause of NRM was infection. Haplo after 2012 (hazard ratio [HR], 0.57; P = .01), younger age (HR, 0.82; P = .02), and receipt of a reduced-intensity conditioning (RIC) regimen (HR, 0.53; P = .01) were independently associated with lower NRM. The 2-year overall survival rate was 36% and improved after 2012 (29% vs 47% before 2012; P = .02); and it was higher for patients who underwent transplantation in CR1 (41% vs 29%; P = .01). In multivariate analysis, haplo after 2012 (HR, 0.54; P = .003) and receipt of a RIC regimen (HR, 0.54; P = .005) were independently associated with better overall survival. Similarly, leukemia-free survival and GvHD-free/relapse-free survival (GRFS) improved over time: the leukemia-free survival rate was 31% (25% vs 43% in the groups who underwent transplantation before and after 2012, respectively; P = .05), and the GRFS rate was 24% (19% vs 34%, respectively; P = .09). In addition, leukemia-free survival and GRFS improved among patients who received a RIC regimen.The outcome of patients with acute leukemia who underwent T-cell-depleted haplo has improved over time. Cancer 2018;124:2142-50. © 2018 American Cancer Society." @default.
• W2794187412 created "2018-03-29" @default.
• W2794187412 creator A5000244387 @default.
• W2794187412 creator A5002578778 @default.
• W2794187412 creator A5012796837 @default.
• W2794187412 creator A5020996390 @default.
• W2794187412 creator A5021123903 @default.
• W2794187412 creator A5026667594 @default.
• W2794187412 creator A5040417184 @default.
• W2794187412 creator A5053216997 @default.
• W2794187412 creator A5058925624 @default.
• W2794187412 creator A5066624700 @default.
• W2794187412 creator A5070029054 @default.
• W2794187412 creator A5086668079 @default.
• W2794187412 date "2018-02-22" @default.
• W2794187412 modified "2023-09-30" @default.
• W2794187412 title "T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT)" @default.
• W2794187412 cites W1890840545 @default.
• W2794187412 cites W1995090169 @default.
• W2794187412 cites W2011609866 @default.
• W2794187412 cites W2020172209 @default.
• W2794187412 cites W2027619061 @default.
• W2794187412 cites W2045470396 @default.
• W2794187412 cites W2046689400 @default.
• W2794187412 cites W2050921203 @default.
• W2794187412 cites W2055313377 @default.
• W2794187412 cites W2099694564 @default.
• W2794187412 cites W2114077193 @default.
• W2794187412 cites W2127080762 @default.
• W2794187412 cites W2130040182 @default.
• W2794187412 cites W2147068163 @default.
• W2794187412 cites W2167765664 @default.
• W2794187412 cites W2219110027 @default.
• W2794187412 cites W2219528388 @default.
• W2794187412 cites W2299339456 @default.
• W2794187412 cites W2302206374 @default.
• W2794187412 cites W2317548431 @default.
• W2794187412 cites W2595261904 @default.
• W2794187412 cites W2621546725 @default.
• W2794187412 doi "https://doi.org/10.1002/cncr.31310" @default.
• W2794187412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29469924" @default.
• W2794187412 hasPublicationYear "2018" @default.
• W2794187412 type Work @default.
• W2794187412 sameAs 2794187412 @default.
• W2794187412 citedByCount "8" @default.
• W2794187412 countsByYear W27941874122018 @default.
• W2794187412 countsByYear W27941874122019 @default.
• W2794187412 countsByYear W27941874122020 @default.
• W2794187412 countsByYear W27941874122021 @default.
• W2794187412 crossrefType "journal-article" @default.
• W2794187412 hasAuthorship W2794187412A5000244387 @default.
• W2794187412 hasAuthorship W2794187412A5002578778 @default.
• W2794187412 hasAuthorship W2794187412A5012796837 @default.
• W2794187412 hasAuthorship W2794187412A5020996390 @default.
• W2794187412 hasAuthorship W2794187412A5021123903 @default.
• W2794187412 hasAuthorship W2794187412A5026667594 @default.
• W2794187412 hasAuthorship W2794187412A5040417184 @default.
• W2794187412 hasAuthorship W2794187412A5053216997 @default.
• W2794187412 hasAuthorship W2794187412A5058925624 @default.
• W2794187412 hasAuthorship W2794187412A5066624700 @default.
• W2794187412 hasAuthorship W2794187412A5070029054 @default.
• W2794187412 hasAuthorship W2794187412A5086668079 @default.
• W2794187412 hasBestOaLocation W27941874121 @default.
• W2794187412 hasConcept C120665830 @default.
• W2794187412 hasConcept C121332964 @default.
• W2794187412 hasConcept C126322002 @default.
• W2794187412 hasConcept C141071460 @default.
• W2794187412 hasConcept C207103383 @default.
• W2794187412 hasConcept C2776863199 @default.
• W2794187412 hasConcept C2777408962 @default.
• W2794187412 hasConcept C2778461978 @default.
• W2794187412 hasConcept C2778729363 @default.
• W2794187412 hasConcept C2911091166 @default.
• W2794187412 hasConcept C44249647 @default.
• W2794187412 hasConcept C61511704 @default.
• W2794187412 hasConcept C71924100 @default.
• W2794187412 hasConcept C88879693 @default.
• W2794187412 hasConcept C90924648 @default.
• W2794187412 hasConceptScore W2794187412C120665830 @default.
• W2794187412 hasConceptScore W2794187412C121332964 @default.
• W2794187412 hasConceptScore W2794187412C126322002 @default.
• W2794187412 hasConceptScore W2794187412C141071460 @default.
• W2794187412 hasConceptScore W2794187412C207103383 @default.
• W2794187412 hasConceptScore W2794187412C2776863199 @default.
• W2794187412 hasConceptScore W2794187412C2777408962 @default.
• W2794187412 hasConceptScore W2794187412C2778461978 @default.
• W2794187412 hasConceptScore W2794187412C2778729363 @default.
• W2794187412 hasConceptScore W2794187412C2911091166 @default.
• W2794187412 hasConceptScore W2794187412C44249647 @default.
• W2794187412 hasConceptScore W2794187412C61511704 @default.
• W2794187412 hasConceptScore W2794187412C71924100 @default.
• W2794187412 hasConceptScore W2794187412C88879693 @default.
• W2794187412 hasConceptScore W2794187412C90924648 @default.
• W2794187412 hasLocation W27941874121 @default.
• W2794187412 hasLocation W27941874122 @default.
• W2794187412 hasOpenAccess W2794187412 @default.
• W2794187412 hasPrimaryLocation W27941874121 @default.
• W2794187412 hasRelatedWork W1965897738 @default.
• W2794187412 hasRelatedWork W2004368639 @default.
• W2794187412 hasRelatedWork W2009733242 @default.

• next